Dudediligence.

CVS Health Corporation

CVSNYSE · Retail-Drug Stores and Proprietary Stores
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$9,524,686

3 notices · 104,368 sh

Oct 2025 to Oct 2026

Reported ·

$323.7M

8 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 8 reported sales carry the 10b5-1 box. Together they are 0.27% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-05-20: AGUIRRE FERNANDO, Form 1442026-05-21: FARAH ROGER N, Form 1442026-05-08: TILAK MANDADI, Form 1442026-05-08: Mandadi Tilak, sold2026-05-19: ROBBINS LARRY, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-05-21FARAH ROGER N, Director$263,886
2,817 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-20AGUIRRE FERNANDO, Director$3,030,080
32,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-08TILAK MANDADI, EVP, Chief Exp & Tech Officer$6,230,719
69,551 shno plan date144 ↗
Form 4, 2026-05-11: sold 69,551 at $89.58 Form 4 ↗